Literature DB >> 28483268

Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.

Yasuhiro Tsutani1, Takeshi Mimura1, Yuichiro Kai1, Masaoki Ito1, Keizo Misumi1, Yoshihiro Miyata1, Morihito Okada2.   

Abstract

OBJECTIVE: Since the prognosis after standard lobectomy for non-small cell lung cancer (NSCLC) in patients with interstitial lung disease (ILD) is poor, we investigated the possibility of sublobar resection for the improvement of the surgical results in such patients.
METHODS: Of 796 consecutive patients with clinical stage I NSCLC who underwent pulmonary resection, 107 were diagnosed with ILD using high-resolution computed tomography (HRCT). Overall survivals (OS) were compared between patients with non-ILD and those with ILD or between patients with ILD who underwent lobectomy and those who underwent sublobar resection. ILD patterns consisted of usual interstitial pneumonia (UIP), possible UIP, and inconsistent with UIP. The log-rank statistics and Cox proportional hazard models were used to test for survival differences.
RESULTS: OS was significantly lower in patients with "ILD inconsistent with UIP" pattern (hazard ratio [HR], 2.66; 95% confidence interval [CI], 1.19-5.97; P = .014), or "ILD with possible UIP or UIP" patterns (HR, 2.38; 95% CI, 1.76-3.21; P < .001) compared with patients with non-ILD. No significant difference in OS was observed between patients with ILD who underwent either lobectomy or sublobar resection (HR, 1.82; 95% CI, 0.81-4.06; P = .19). Multivariable Cox analysis demonstrated diffusing capacity of the lung for carbon monoxide (HR, 0.95; 95% CI, 0.91-0.99; P = .009) and not surgical procedure (HR, 2.76; 95% CI, 0.83-9.16; P = .099), as an independent prognostic factor for OS.
CONCLUSIONS: Sublobar resection may be a potential alternative choice for clinical stage I NSCLC with ILD on HRCT.
Copyright © 2017 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  interstitial lung disease; interstitial pneumonia; lobectomy; non–small cell lung cancer; segmentectomy; sublobar resection; wedge resection

Mesh:

Year:  2017        PMID: 28483268     DOI: 10.1016/j.jtcvs.2017.03.116

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Surgical Options for Resectable Lung Adenosquamous Carcinoma: A Propensity Score-Matched Analysis.

Authors:  Shuncang Zhu; Tao Ge; Yicheng Xiong; Jing Zhang; Di Zhu; Liangdong Sun; Nan Song; Peng Zhang
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

2.  Prognosis of limited resection versus lobectomy in elderly patients with invasive lung adenocarcinoma with tumor size less than or equal to 2 cm.

Authors:  Tianxiang Chen; Jizhuang Luo; Rui Wang; Haiyong Gu; Yu Gu; Qingyuan Huang; Yiyang Wang; Jiajie Zheng; Yunhai Yang; Heng Zhao
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

3.  Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients.

Authors:  Kakuhiro Yamaguchi; Satoshi Nakao; Hiroshi Iwamoto; Atsushi Kagimoto; Yoshinori Handa; Shinjiro Sakamoto; Yasushi Horimasu; Takeshi Masuda; Takahiro Mimae; Shintaro Miyamoto; Taku Nakashima; Yasuhiro Tsutani; Kazunori Fujitaka; Yoshihiro Miyata; Hironobu Hamada; Morihito Okada; Noboru Hattori
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

4.  Prognosis of resected non-small cell lung cancer with pleural plaques on intrathoracic findings.

Authors:  Atsushi Kagimoto; Takeshi Mimura; Atsushi Kamigaichi; Yoshinori Yamashita
Journal:  BMC Cancer       Date:  2022-04-28       Impact factor: 4.638

5.  Is operation safe for lung cancer patients with interstitial lung disease on computed tomography?

Authors:  Hai Tang; Yijiu Ren; Yunlang She; Chenyang Dai; Tingting Wang; Hang Su; Weiyan Sun; Gening Jiang; Chang Chen
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

Review 6.  A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors.

Authors:  Brett C Bade; Justin D Blasberg; Vincent J Mase; Ulas Kumbasar; Andrew X Li; Henry S Park; Roy H Decker; David C Madoff; Whitney S Brandt; Gavitt A Woodard; Frank C Detterbeck
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.